Search Results - "Hatlevoll, R"

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group by Kristiansen, K, Hagen, S, Kollevold, T, Torvik, A, Holme, I, Nesbakken, R, Hatlevoll, R, Lindgren, M, Brun, A, Lindgren, S, Notter, G, Andersen, A P, Elgen, K

“…In a controlled, prospective, randomized investigation, started in 1974, 118 patients with supratentorial astrocytoma Grade III--IV were divided into three…”
Get more information

Cisplatin and Etoposide Regimen Is Superior to Cyclophosphamide, Epirubicin, and Vincristine Regimen in Small-Cell Lung Cancer: Results From a Randomized Phase III Trial With 5 Years’ Follow-Up by SUNDSTRØM, Stein, BREMNES, Roy M, SKOVLUND, Eva, HANNISDAL, Einar, AAMDAL, Steinar, KAASA, Stein, AASEBØ, Ulf, HATLEVOLL, Reidulv, DAHLE, Ragnar, BOYE, Nils, WANG, Mari, VIGANDER, Tor, VILSVIK, Jan

“…To investigate whether chemotherapy with etoposide and cisplatin (EP) is superior to cyclophosphamide, epirubicin, and vincristine (CEV) in small-cell lung…”
Get full text

Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma by Lindegaard, K F, Mørk, S J, Eide, G E, Halvorsen, T B, Hatlevoll, R, Solgaard, T, Dahl, O, Ganz, J

“…The postoperative survival time of 170 nonrandomized patients treated for cerebral oligodendrogliomas in Norway from 1953 to 1977 was studied. Survival times…”
Get more information

The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up by Bremnes, Roy M, Sundstrom, Stein, Aasebø, Ulf, Kaasa, Stein, Hatlevoll, Reidulv, Aamdal, Steinar

“…We have evaluated the prognostic value of 22 pretreatment attributes in 436 small cell lung cancer (SCLC) patients included in a prospective multicenter study…”
Get full text

Hypofractionated Palliative Radiotherapy (17 Gy per two fractions) in Advanced Non–Small-Cell Lung Carcinoma Is Comparable to Standard Fractionation for Symptom Control and Survival: A National Phase III Trial by SUNDSTRØM, Stein, BREMNES, Roy, AASEBØ, Ulf, AAMDAL, Steinar, HATLEVOLL, Reidulv, BRUNSVIG, Paal, JOHANNESSEN, Dag Clement, KLEPP, Olbjørn, FAYERS, Peter M, KAASA, Stein

“…To investigate whether the effect of hypofractionated thoracic radiotherapy (TRT) is comparable to more standard fractionated radiotherapy (RT) in advanced…”
Get full text

A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844 by Karim, A B, Maat, B, Hatlevoll, R, Menten, J, Rutten, E H, Thomas, D G, Mascarenhas, F, Horiot, J C, Parvinen, L M, van Reijn, M, Jager, J J, Fabrini, M G, van Alphen, A M, Hamers, H P, Gaspar, L, Noordman, E, Pierart, M, van Glabbeke, M

“…Cerebral low-grade gliomas (LGG) in adults are mostly composed of astrocytomas, oligodendrogliomas, and mixed oligoastrocytomas. There is at present no…”
Get more information

Myelopathy following radiotherapy of bronchial carcinoma with large single fractions: a retrospective study by Hatlevoll, R, Høst, H, Kaalhus, O

“…A series of 387 patients with bronchial carcinoma treated with a concentrated split course regimen was surveyed for radiation myelitis. The total dose was 38…”
Get more information

Sightsaving therapy in retinoblastoma. Experience with external megavoltage radiotherapy by Monge, O R, Flage, T, Hatlevoll, R, Vermund, H

“…In Norway, sightsaving therapy in retinoblastoma has only been given to least affected eyes in bilaterally affected children. The results in 8 eyes given…”
Get more information

Irradiation, chemotherapy and surgery in esophageal cancer: a randomized clinical study. The first Scandinavian trial in esophageal cancer by Andersen, A P, Berdal, P, Edsmyr, F, Hagen, S, Hatlevoll, R, Nygaard, K, Ottosen, P, Peterffy, P, Kongsholm, H, Elgen, K

“…In a randomized trial, irradiation alone (35 Gy) or irradiation (30 Gy) and bleomycin was given as preoperative treatment of esophageal cancer. In inoperable…”
Get more information

Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer by Nygaard, Knut, Hagen, Steinar, Hansen, Hanne Sand, Hatlevoll, Reidulv, Hultborn, Ragnar, Jakobsen, Anders, Mäntyla, Matti, Modig, Hans, Munck‐Wikland, Eva, Rosengren, Bengt, Tausjø, Johan, Elgen, Kjell

“…In a prospective multicenter study, 186 patients with squamous cell esophageal carcinoma, who after evaluation were considered suitable for surgery, were…”
Get full text

Weekly docetaxel with concurrent radiotherapy in locally advanced non-small cell lung cancer: A Phase I/II study with 5 years’ follow-up by Brunsvig, Paal F., Hatlevoll, Reidulv, Berg, Randi, Lauvvang, Grethe, Øwre, Kristin, Wang, Mari, Aamdal, Steinar

“…This Phase I/II study investigated weekly docetaxel (Taxotere ®) with concurrent radiotherapy in 42 patients with untreated stage III non-small cell lung…”
Get full text

Medulloblastoma. Postoperative treatment by Wang, M, Hatlevoll, R

Get more information

A phase I/II study of Docetaxel (Taxotere) combined with concurrent radiation therapy in locally advanced non-small cell lung cancer (NSCLC) by Aamdal, S, Lauvvang, G, Owre, K, Hatlevoll, R, Armellini, J

Get full text

Symptomatic treatment versus combination chemotherapy for patients with extensive non-small cell lung cancer by Kaasa, S, Lund, E, Thorud, E, Hatlevoll, R, Høst, H

“…In a randomized clinical trial, 87 patients with inoperable, extensive non-small cell lung cancer (NSCLC) were randomized to receive either combination…”
Get more information

Docetaxel (D, Taxotere®) with concurrent radiation in locally advanced non-small cell lung cancer (NSCLC) by Aamdal, S., Hagen, I., Avril, I., Lauvvang, G., Øwre, K., Hatlevoll, R.

Get full text

328 A phase III study of docetaxel (taxotere) combined with radiation in locally advanced non-small-cell lung cancer (NSCLC) by Aamdal, S., Wibe, E., Hallén, M.N., Berg, R., Hatlevoll, R.

Get full text

328 A phase [formula omitted] study of docetaxel (taxotere) combined with radiation in locally advanced non-small-cell lung cancer (NSCLC) by Aamdal, S., Wibe, E., Hallén, M.N., Berg, R., Hatlevoll, R.

Get full text

Oligodendroglioma: incidence and biological behavior in a defined population by Mørk, S J, Lindegaard, K F, Halvorsen, T B, Lehmann, E H, Solgaard, T, Hatlevoll, R, Harvei, S, Ganz, J

“…The cases of 208 patients with histologically confirmed oligodendrogliomas were studied. The incidence represents 4.2% of all primary brain tumors diagnosed in…”
Get more information

Endobronchial radiotherapy for malignant bronchial obstruction or recurrence by Hatlevoll, R, Karlsen, K O, Skovlund, E

“…Forty-five lung cancer patients who had recurrence and/or endobronchial obstruction were treated with intrabronchial radiotherapy (IBRT). The majority had been…”
Get more information

Long-term survival following surgery and radiotherapy of brain tumors in childhood by Lote, K, Hatlevoll, R, Bakke, S J, Due-Tønnesen, B, Helseth, E, Lundar, T, Glomstein, A, Skullerud, K

“…Brain tumours are seen in about one third of children with neoplastic disease. Treatment usually includes surgery and/or radiotherapy. Radiotherapy may have…”
Get full text